Decoding 5 Analyst Evaluations For Maravai LifeSciences
Decoding 5 Analyst Evaluations For Maravai LifeSciences
解讀5位分析師對maravai lifesciences的評估
A clear picture of Maravai LifeSciences's perception among financial experts is painted...Analysts' ratings for Maravai LifeSciences (NASDAQ:MRVI) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
過去一季度對Maravai LifeSciences（納斯達克股票代碼：MRVI）的分析師評級從看好到看淡不一，由5位分析師提供。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.2, a high estimate of $15.00, and a low estimate of $7.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 7.27%.
分析師們 12 個月的目標價預測揭示，平均目標價爲 $10.2，高估價爲 $15.00，低估價爲 $7.00。 情緒出現負向變化，因爲分析師們將平均目標價格下調了 7.27%。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
A clear picture of Maravai LifeSciences's perception among financial experts is painted...
通過對最近分析師行動進行徹...
登入免費觀看全文
登入/註冊
熱門討論
中概股財報季火熱：驚喜盈利能否延續漲勢？
1. 哪些行業可能成為本輪財報季的市場焦點？ 2. 在政府強調科技創新和可持續發展的背景下，你認為哪些行業具有最大的增長潜力？
Moomoo News Global
03/04 23:26
中國兩會：會議前後股票價格變動的關鍵要點